ALX 40-4C
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


ALX 40-4C
Description:
ALX 40-4C is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1; ALX 40-4C Trifluoroacetate also acts as an antagonist of the APJ receptor, with an IC50 of 2.9 μM.UNSPSC:
12352202Target:
Apelin Receptor (APJ) ; CXCRType:
PeptidesRelated Pathways:
GPCR/G Protein; Immunology/InflammationApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Infection; EndocrinologyAssay Protocol:
https://www.medchemexpress.com/ALX_40-4C.htmlSolubility:
10 mM in H2OSmiles:
N=C (N) NCCC[C@H] (C (N) =O) NC ([C@@H] (CCCNC (N) =N) NC ([C@@H] (CCCNC (N) =N) NC ([C@@H] (CCCNC (N) =N) NC ([C@@H] (CCCNC (N) =N) NC ([C@@H] (CCCNC (N) =N) NC ([C@@H] (CCCNC (N) =N) NC ([C@@H] (CCCNC (N) =N) NC ([C@H] (NC (C) =O) CCCNC (N) =N) =O) =O) =O) =O) =O) =O) =O) =OMolecular Formula:
C56H113N37O10Molecular Weight:
1464.74References & Citations:
[1]Doranz BJ, et al. Safe use of the CXCR4 inhibitor ALX40-4C in humans. AIDS Res Hum Retroviruses. 2001 Apr 10;17 (6) :475-86.|[2]Armand-Ugón M, et al. HIV-1 resistance to the gp41-dependent fusion inhibitor C-34. Antiviral Res. 2003 Jul;59 (2) :137-42.|[3]Zhou N, et al. Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1. Virology. 2003 Jul 20;312 (1) :196-203.Shipping Conditions:
Room temperatureScientific Category:
PeptidesClinical Information:
No Development ReportedIsoform:
CXCR4CAS Number:
143413-49-4
